Key Highlights
- Rocket Lab (RKLB) shares jumped 7% on Wednesday following the completion of its at-the-market equity offering program
- The aerospace company successfully sold 6,726,862 shares, generating roughly $474 million in gross proceeds
- The firm also established collared forward agreements covering 7,451,200 shares, potentially yielding up to $642 million
- Capital raised will be allocated toward expansion initiatives, possible acquisitions, and general corporate purposes
- On April 7, Citizens JMP Securities upgraded RKLB to Outperform, assigning an $85 price target
Rocket Lab (RKLB) successfully concluded its at-the-market equity offering program this Wednesday, offloading 6,726,862 shares and securing approximately $474 million in gross proceeds, prior to deducting commissions and associated costs.
The capital raise was executed under a prospectus supplement that the company filed on March 17, 2026, which granted authorization to issue up to $1 billion worth of shares through at-the-market transactions.
In conjunction with the direct share sales, Rocket Lab structured collared forward agreements encompassing 7,451,200 shares. These arrangements guarantee minimum proceeds of $474 million while establishing a maximum potential of roughly $642 million.
The collared forward contracts are scheduled to reach maturity in April 2028. Final proceeds will vary based on whether Rocket Lab opts for early settlement and the specific cap and floor prices established within each separate transaction.
Rocket Lab announced its intention to deploy the raised capital toward supporting future expansion, exploring potential acquisition opportunities, and addressing general corporate requirements and working capital demands. The company did not disclose any specific acquisition candidates.
Shares rallied following the announcement, buoyed by a broader upward trend across equity markets on Wednesday.
Citizens Issues Outperform Rating
Just one day prior to the offering’s completion, on April 7, Citizens elevated RKLB from Market Perform to Outperform, establishing a price objective of $85.
The investment firm highlighted Rocket Lab’s launch operations, defense-oriented space systems, and what analysts described as an increasingly “clearer path toward higher-value” space services as key drivers behind the rating improvement.
Citizens characterized the current valuation level as attractive, citing a “confluence of several strategic and macroeconomic factors.” The firm anticipates “solid upside potential” throughout the coming 12 months and in subsequent periods.
Analysts also identified favorable geopolitical dynamics and robust funding conditions within the space industry as positive catalysts for the company’s growth trajectory.
The timing of the upgrade coincided with Rocket Lab finalizing a capital raise that surpassed the minimum threshold established in its forward contracts.
Equity Offering Structure
The at-the-market offering mechanism provides Rocket Lab with considerable flexibility regarding timing and pricing decisions, unlike traditional offerings that require locking in predetermined prices.
This framework enabled the company to capitalize on favorable market conditions, which evidently materialized during this week’s transactions.
The collared forward arrangement also establishes a minimum floor for proceeds, effectively mitigating downside exposure to potential price volatility prior to the April 2028 settlement dates.
Combining the shares already distributed with the forward commitments, Rocket Lab has successfully raised or secured commitments totaling between approximately $948 million and $1.116 billion through this comprehensive program.
The $1 billion offering limit established in the March 17 prospectus supplement has been effectively achieved or surpassed when both components are factored together.
Wednesday’s closing price demonstrated investor confidence in a capital raise that met—and potentially exceeded—the company’s publicly stated objectives.
